Justin Teeguarden

utbildad vid: University of Wisconsin–Madison, University of California, Davis

sysselsättning: forskare

Serier

Det finns ingenting här

Skapa en ny serie

Verk

Det finns ingenting här

Skapa ett nytt verk

Artiklar 46

Datum

Titel

Författare

2021-03-14

Night shift schedule causes circadian dysregulation of DNA repair genes and elevated DNA damage in humans

Bala S C Koritala, Kenneth I Porter, Rajendra P Gajula, Justin Teeguarden, Hans P A Van Dongen, Jason McDermott, Shobhan Gaddameedhi
2018-03-13

Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women I: Serum levels, variability and the basis for urinary biomonitoring of serum estrogenicity.

Justin Teeguarden
2018-12-13

Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: Total estrogenicity calculations accounting for competitive protein and receptor binding and potency

Justin Teeguarden
2016-05-30

Urine and serum biomonitoring of exposure to environmental estrogens II: Soy isoflavones and zearalenone in pregnant women

Justin Teeguarden
2015-09

24-hour human urine and serum profiles of bisphenol A following ingestion in soup: individual pharmacokinetic data and emographics

Justin Teeguarden
2014-05-01

An integrated approach for the in vitro dosimetry of engineered nanomaterials

Philip Demokritou, Justin Teeguarden
2014-12

A proposal for assessing study quality: Biomonitoring, Environmental Epidemiology, and Short-lived Chemicals (BEES-C) instrument

Dana Boyd Barr, Justin Teeguarden, Jon R. Sobus, Greet Schoeters, Clifford Weisel
2014-09-30

Comparative iron oxide nanoparticle cellular dosimetry and response in mice by the inhalation and liquid cell culture exposure routes

Justin Teeguarden, Katrina M. Waters
2014-12-01

Low-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress

Justin Teeguarden
2013-08-27

Dysregulation of macrophage activation profiles by engineered nanoparticles

Vamsi Kodali, Justin Teeguarden, Joel G. Pounds, Susan C Tilton
2013-08-28

Nonlinear responses for chromosome and gene level effects induced by vinyl acetate monomer and its metabolite, acetaldehyde in TK6 cells

Justin Teeguarden
2013-08-17

Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population?

Justin Teeguarden
2013-05-31

Physiologically-based pharmacokinetic model for Fentanyl in support of the development of Provisional Advisory Levels

Justin Teeguarden
2012-02

Aerosolized ZnO nanoparticles induce toxicity in alveolar type II epithelial cells at the air-liquid interface

Justin Teeguarden, Joel G. Pounds, Alexander Laskin
2012-10-23

A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans

Justin Teeguarden
2011-03

Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice

Justin Teeguarden, Joel G. Pounds, Katrina M. Waters, Anna A. Shvedova, Elena R. Kisin, Ashley R. Murray, Susan M Varnum, Jöns Jacob Berzelius
2011-01-01

Testing in EHS: What is the Current Status of Experimentation?

Ajay S Karakoti, Joel G. Pounds, Justin Teeguarden
2011-06-24

Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure

Antonia M. Calafat, Justin Teeguarden
2010-11-30

ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies

Justin Teeguarden, Joel G. Pounds
2008-12-10

Macrophage responses to silica nanoparticles are highly conserved across particle sizes

Justin Teeguarden, Joel G. Pounds, Katrina M. Waters, Brian D Thrall, Richard C Zangar
2008-02-01

Derivation of an inhalation reference concentration based upon olfactory neuronal loss in male rats following subchronic acetaldehyde inhalation

Justin Teeguarden, Melvin E. Andersen
2008-01-01

Pharmacokinetic modeling of manganese in the rat IV: Assessing factors that contribute to brain accumulation during inhalation exposure

Justin Teeguarden, Melvin E. Andersen
2008-02-01

A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry

Justin Teeguarden
2007-12-01

Submicrometer and nanoscale inorganic particles exploit the actin machinery to be propelled along microvilli-like structures into alveolar cells

Dehong Hu, Justin Teeguarden, Joel G. Pounds
2007-08-19

Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials

Justin Teeguarden, Brian J. Riley
2007-09-01

Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination

Justin Teeguarden, Melvin E. Andersen
2007-09-01

Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation

Justin Teeguarden, Melvin E. Andersen
2007-09-01

Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics

Justin Teeguarden, Melvin E. Andersen
2006-11-10

Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments

Justin Teeguarden, Joel G. Pounds
2005-02-09

Derivation of a human equivalent concentration for n-butanol using a physiologically based pharmacokinetic model for n-butyl acetate and metabolites n-butanol and n-butyric acid

Justin Teeguarden
2005-03-02

Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach

Justin Teeguarden
2004-03-31

Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry

Justin Teeguarden, Harvey J Clewell

Människa - wd:Q42709513

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer